SMARCA4 and non-small cell lung carcinoma: A549-LN cells were derived from the A549 human non-small cell lung cancer line which has increased sensitivity to oxidative phosphorylation inhibition due to a mutation of the SWI/SNF chromatin remodelling complex member, SMARCA-4 [14].